机译:基于8年内患者的细胞遗传学概况基于细胞遗传学概况的无过敏性黑素瘤的个性化预后
Thomas Jefferson Univ Wills Eye Hosp Ocular Oncol Serv Philadelphia PA 19107 USA;
Thomas Jefferson Univ Wills Eye Hosp Ocular Oncol Serv Philadelphia PA 19107 USA;
Thomas Jefferson Univ Wills Eye Hosp Ocular Oncol Serv Philadelphia PA 19107 USA;
Thomas Jefferson Univ Wills Eye Hosp Ocular Oncol Serv Philadelphia PA 19107 USA;
Thomas Jefferson Univ Wills Eye Hosp Ocular Oncol Serv Philadelphia PA 19107 USA;
Thomas Jefferson Univ Wills Eye Hosp Ocular Oncol Serv Philadelphia PA 19107 USA;
Thomas Jefferson Univ Wills Eye Hosp Ocular Oncol Serv Philadelphia PA 19107 USA;
Thomas Jefferson Univ Wills Eye Hosp Ocular Oncol Serv Philadelphia PA 19107 USA;
Thomas Jefferson Univ Wills Eye Hosp Ocular Oncol Serv Philadelphia PA 19107 USA;
Thomas Jefferson Univ Wills Eye Hosp Ocular Oncol Serv Philadelphia PA 19107 USA;
Thomas Jefferson Univ Wills Eye Hosp Ocular Oncol Serv Philadelphia PA 19107 USA;
Thomas Jefferson Univ Wills Eye Hosp Ocular Oncol Serv Philadelphia PA 19107 USA;
Thomas Jefferson Univ Wills Eye Hosp Ocular Oncol Serv Philadelphia PA 19107 USA;
Univ Penn Sch Med Dept Genet Philadelphia PA 19104 USA;
机译:基于8年内患者的细胞遗传学概况基于细胞遗传学概况的无过敏性黑素瘤的个性化预后
机译:基于种族的葡萄膜黑色素瘤预后8100例:2015年多恩讲座
机译:基于磁珠分离和质谱的葡萄膜黑色素瘤患者人血清肽组图谱
机译:使用MALDI-IMS-MS的UVEAL Melanoma的脂质和蛋白质组学分析和成像
机译:使用药物基因组学方法确定新的胶质母细胞瘤治疗新策略:与患者预后和卡培他滨治疗结果相关的遗传特征。
机译:韩国患者的细胞遗传学和预后性黑素瘤